On April 10, the Department of Health and Human Services (HHS) began distributing the initial $30 billion in COVID-19 relief funding to providers as part of the distribution of the $100 billion fund provided as part of the CARES Act.

This initial distribution of funds will go to hospitals and providers currently enrolled in Medicare and take effect immediately. Facilities and providers are allotted a portion of the $30 billion based on their share of 2019 Medicare fee-for-service (FFS) reimbursements. Therefore, those facilities and providers that billed significant amounts of Medicare FFS in 2019 are the priority in this first phase.

These are payments, not loans, and will not need to be repaid. Fund recipients will be prohibited from balancing billing COVID-19 patients for related services. Additional details from HHS can be found here.

A second phase of targeted distributions to providers is expected to follow soon and will focus on providers in areas particularly impacted by the COVID-19 outbreak, rural providers, and providers of services with lower shares of Medicare FFS reimbursement or who predominantly serve the Medicaid population.
 

Share this

Recent Posts

President’s Message: Academy Teamwork

“Huh?” Is More Than an Interrogatory Palindrome!

Volunteer Spotlight: Riley DeBacker, AuD, PhD

Related Posts

Biden-Harris Administration Releases Playbook to Address Social Determinants of Health (SDOH)

A growing body of evidence demonstrates the connection between health outcomes to income, education, nutrition, housing, environmental exposures, and other social circumstances.  Similarly, studies have shown that interventions addressing SDOH can improve health outcomes and reduce health care costs. In response, the Biden-Harris Administration has released a playbook outlining new or strengthened initiatives that agencies…

Read More

Free Hearing Aids from Cochlear Implant Manufacturer May Violate Fraud and Abuse Laws

The U.S. Department of Health and Human Services Office of Inspector General (OIG) posted on October 25, 2023 Advisory Opinion No. 23-08, in which OIG rejected a proposed arrangement from a cochlear implant device manufacturer (the requestor) that would provide a free hearing aid to certain qualified patients who received a cochlear implant. OIG concluded the…

Read More

Representatives Bilirakis and Cartwright Introduce the Medicare Audiology Access Improvement Act of 2023 (H.R. 6445) 

On November 17, 2023, Representative Gus Bilirakis (R-FL) and Matt Cartwright (D-PA) introduced the Medicare Audiology Access improvement Act (H.R. 6445). This legislation is also co-sponsored by Representatives Johnson (R-OH), Shakowsky (D-IL), Mace (R-SC), Blunt Rochester (D-DE), Fitzpatrick (R-PA), Trone (D-MD), Webster (R-FL), Cohen (D-TN), LaMalfa (R-CA), Grijalva (D-AZ), Foster (D-IL) and Pocan (D-WI). Senators Elizabeth…

Read More